SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-073264
Filing Date
2022-06-22
Accepted
2022-06-22 07:31:04
Documents
15
Period of Report
2022-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2219020d1_8k.htm   iXBRL 8-K 36968
2 EXHIBIT 10.1 tm2219020d1_ex10-1.htm EX-10.1 160144
6 GRAPHIC tm2219020d1_ex10-1img01.jpg GRAPHIC 2726
7 GRAPHIC tm2219020d1_ex10-1img02.jpg GRAPHIC 20227
  Complete submission text file 0001104659-22-073264.txt   446286

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lqda-20220615.xsd EX-101.SCH 3033
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lqda-20220615_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lqda-20220615_pre.xml EX-101.PRE 22595
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2219020d1_8k_htm.xml XML 3683
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

IRS No.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39724 | Film No.: 221030001
SIC: 2834 Pharmaceutical Preparations